NCT04546087

Brief Summary

The cricothyroid membrane acts as a route through which the upper airway can be accessed to provide oxygen and ventilation to patients. Anesthesiologists need to deliver oxygen and ventilation to patients under general anesthesia, where patients may lose the ability to breath for themselves. Access through this membrane to provide oxygen and ventilation is critical in emergency situations where other traditional means to access the airway (e.g. through endotracheal ventilation, supraglottic airway devices or face mask ventilation) have failed. It is known, from previous studies, that due to the physiological changes that occur in labour, the upper airway of the body undergoes changes that can make accessing the airway through traditional means more difficult, specifically during the period of labor, delivery, and just after delivery. Ultrasound is becoming increasingly popular due to its ability both to identify the cricothyroid membrane and to improve success in accessing the airway through the cricothyroid membrane. What is not known, and has not been studied to date, is specifically how the anatomy (i.e. its height and its depth) specifically changes during the period of labour, delivery and just after delivery. The aim of this study would be to scan (using ultrasound) pregnant women's necks once at the very start of their labour, and once within 4 hours of delivery of their baby, to identify how the size and depth of the cricothyroid membrane changes. This information would improve the understanding of how to best approach accessing this membrane in laboring pregnant women. The investigators hypothesize that in labouring third trimester patient, that the depth to the cricothyroid membrane will increase, and there will be no change in the cricothyroid membrane height.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 11, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2022

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

2.2 years

First QC Date

August 28, 2020

Last Update Submit

March 15, 2024

Conditions

Keywords

cricothyroid membranepregnancyultrasound

Outcome Measures

Primary Outcomes (1)

  • Cricothyroid membrane position change

    Difference between the depth from the skin to the cricothyroid membrane- tracheal interface change ultrasound between the onset of established labor and following delivery of the baby and placenta.

    24 hours

Secondary Outcomes (1)

  • Cricothyroid membrane size change

    24 hours

Study Arms (1)

Ultrasound

EXPERIMENTAL

Ultrasound measurements of the cricothyroid membrane.

Device: Ultrasound

Interventions

Ultrasound scan of the cricothyroid membrane

Ultrasound

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age \>=18 years old
  • Pregnant patients in third trimester (\>28/40 weeks)
  • Ability to understand the rationale of the study assessments and to provide signed consent.

You may not qualify if:

  • Neck arthritis
  • Cervical stenosis
  • Known cervical degenerative disc disease
  • Rheumatoid Arthritis
  • Any restriction of neck movement
  • Upper limb neurology
  • Patient refusal
  • Patients not in established labour.
  • Patients undergoing cesarean section
  • Known distorted airway anatomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G1X5, Canada

Location

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Eric You-Ten, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 11, 2020

Study Start

September 1, 2020

Primary Completion

November 2, 2022

Study Completion

November 2, 2022

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations